| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10689260 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 458 journal articles in the PubMed database | Email to a friend | | |
| Hasdai D, Holmes DR, Criger DA, et al.
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am Heart J 2000 Mar; 139(3):454-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 1998 Aug 13; 339(7):436-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Labinaz M, Kilaru R, Pieper K, et al.
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Circulation 2002 Jan 22; 105(3):322-7.
Abstract | Full Citation | Find Related Articles | | Lincoff AM, Harrington RA, Califf RM, et al.
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Circulation 2000 Sep 5; 102(10):1093-100.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mahaffey KW, Harrington RA, Simoons ML, et al.
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Circulation 1999 May 11; 99(18):2371-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Labinaz M, Kaul P, Harrington RA, et al.
Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Can J Cardiol 2004 Jun; 20(8):773-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | McClure MW, Berkowitz SD, Sparapani R, et al.
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Circulation 1999 Jun 8; 99(22):2892-900.
Abstract | Full Citation | Find Related Articles | | Fintel DJ, Ledley GS
Management of patients with non-ST-segment elevation acute coronary syndromes: insights from the PURSUIT trial. [Journal Article, Review]
Clin Cardiol 2000 Sep.:V1-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zeymer U
The role of eptifibatide in patients undergoing percutaneous coronary intervention. [JOURNAL ARTICLE]
Expert Opin Pharmacother 2007 Jun; 8(8):1147-1154.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
